Analysis of Genetic Influence of HLA-DRB1, IL4R, and FcγRIIb on Radiographic Responses to Methotrexate Monotherapy or Adalimumab Plus Methotrexate Through 26 Weeks in Patients with Early Rheumatoid Arthritis

被引：0

作者：

Skapenko, Alla ^{[1
]}

Smolen, Josef ^{[2
,3
]}

Kavanaugh, Arthur ^{[4
]}

Santra, Sourav ^{[5
]}

Kupper, Hartmut ^{[6
]}

Peterson, Theresa ^{[5
]}

Schulze-Koops, Hendrik ^{[1
]}

机构：

[1] Univ Munich, Munich, Germany

[2] Med Univ Vienna, Vienna, Austria

[3] Hietzing Hosp, Vienna, Austria

[4] Univ Calif San Diego, La Jolla, CA 92093 USA

[5] Abbott Labs, Abbott Pk, IL 60064 USA

[6] Abbott, Ludwigshafen, Germany

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

154

引用

页码：S56 / S56

页数：1

共 4 条

[1] Genetic Effects of HLA-DRB1, IL4R, and FcγRIIb On Long-Term Treatment Responses in Patients with Early Rheumatoid Arthritis: 78-Week Results of a Phase 4 Study.
Skapenko, Alla
Smolen, Josef S.
Kavanaugh, Arthur
Arora, Vipin
Kupper, Hartmut
Schulze-Koops, Hendrik
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S431 - S431
[2] The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept
Criswell, LA
Lum, RF
Turner, KN
Woehl, B
Zhu, YQ
Wang, JY
Tiwari, HK
Edberg, JC
Kimberly, RP
Moreland, LW
Seldin, MF
Bridges, SL
ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : 2750 - 2756
[3] Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
Detert, Jacqueline
Bastian, Hans
Listing, Joachim
Weiss, Anja
Wassenberg, Siegfried
Liebhaber, Anke
Rockwitz, Karin
Alten, Rieke
Krueger, Klaus
Rau, Rolf
Simon, Christina
Gremmelsbacher, Eva
Braun, Tanja
Marsmann, Bettina
Hoehne-Zimmer, Vera
Egerer, Karl
Buttgereit, Frank
Burmester, Gerd-R
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) : 844 - 850
[4] INITIAL ADALIMUMAB PLUS METHOTREXATE TREATMENT PREVENTS JOINT DESTRUCTION IRRESPECTIVE OF TREATMENT DURATION IN JAPANESE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: POST-HOC ANALYSIS OF HOPEFUL 1 AND 2 STUDIES
Tanaka, Y.
Yamanaka, H.
Ishiguro, N.
Miyasaka, N.
Kawana, K.
Kubo, T.
Kuroki, A.
Takeuchi, T.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 487 - 487

← 1 →